November 7, 2014 -
Posted on November 07 , 2014
MolecuLight Inc. (Toronto, Canada) announced today a multi-project based research agreement with the University Health Network (UHN, Toronto, Canada) aimed at advancing their new handheld optical imaging technology enabling real-time bacterial imaging in wounds at the point-of-care.
Under the terms of the Agreement, MolecuLight Inc. will
… Read More
MolecuLight is SOC ll®
Type l Accredited:
MolecuLight awarded
Premier’s Technology
Breakthrough Designation
MolecuLight i:X
is designated as a:
MolecuLight included
in ISWCAP Consensus
Guidelines:
MolecuLight is a proud
corporate member of:
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.